Human Genome Sciences Reports Initial Results of randomized phase 2 trial of HGS – ETR1 in combination with bortezomib in advanced multiple myelomaHuman Genome Sciences reported initial topline results from an ongoing randomized Phase 2 clinical trial of its TRAIL receptor antibody HGS – ETR1 in combination with bortezomib in patients with advanced multiple myeloma. The first data from the multiple myeloma study show that HGS – ETR1 is well tolerated and suggest that disease response was comparable for this combination vs no prescription canadian pharmacy . Bortezomib alone. We continue to excited about HGS – ETR1 and our TRAIL receptor antibody program, said David C. Executive Vice President, Research and Development, The TRAIL-mediated apoptosis pathway is an important area of cancer research and agonistic antibodies to this target offer great promise. HGS – ETR1 is the most advanced of any product in development them this, kg is a these chemotherapy combination trials currently ongoing to evaluate its potential for the treatment of certain cancers. We look forward to maturing results from all three studies. Taken together, these results will inform our decision whether to advance HGS – ETR1 to 3 development. .
Best dentist says to brush your teeth – The Right WayEach brush their teeth, but few do so properly. Jan Linhart, America’s America’s best dentists, claims that to improve by focusing on key brushing techniques, everyone can their oral health. Says: says: ‘brushes too fast too fast two of the most common mistakes people make when brushing your teeth. ‘He says, choose a toothbrush with soft nylon bristles rolling gentle contact with the teeth and gums while brushing. The brush should also be comfortable to hold and have a head small enough to comfortably each tooth.
Publish. Kaiser Family Foundation.